FDA Inspection
Innovative Intrathecal Solutions, Inc. dba Innovative Compounding PharmacyInnovative Intrathecal Solutions, Inc. dba Innovative Compounding Pharmacy – FDA Inspection, Feb 20, 2020
Record Details
This FDA Inspection record concerns Innovative Intrathecal Solutions, Inc. dba Innovative Compounding Pharmacy, with an inspection on February 20, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- February 20, 2020
- Product Type
- Drugs
View Company Profile
ID · 79c384ba-cdbb-48a3-8155-65af9c4e29a2
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1119189
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Innovative Intrathecal Solutions, Inc. dba Innovative Compounding Pharmacy
2| Date | Classification | Office | Project area |
|---|---|---|---|
| October 26, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 18, 2017 | Not classified | Los Angeles District Office | Drug Quality Assurance |
Other documents for Innovative Intrathecal Solutions, Inc. dba Innovative Compounding Pharmacy
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.